API
< Back to situations

[ORGANIZATION]

Ibima Plataforma BIONAND

Featured in 2 tracked stories · first seen

Situations

[ACTIVE] [BUSINESS] [US] [CN] [DE]

Moderna and Merck melanoma vaccine clinical trials

19 clusters · 556 sources · last updated

Latest: BioNTech and Moderna face mixed clinical and market outlooks

Moderna and Merck (MSD) have reported positive Phase 3 clinical trial results for intismeran autogene (V940), an experimental personalized mRNA cancer vaccine. The INTerpath-001 trial, which administered the vaccine alon

Also covered in